Business Daily.
.
The Times Real Estate
A+ R A-

TSRI Scientists Design Nicotine Vaccine that Provokes Robust Immune Response

E-mail Print PDF
When a promising nicotine vaccine failed in clinical trials a few years ago, scientists from The Scripps Research Institute were determined to keep trying to help smokers overcome their addiction. Now the team has designed a more effective nicotine vaccine and proven that the structures of molecules used in vaccines is critical.

Read more http://www.alphagalileo.org/ViewItem.aspx?ItemId=148739&CultureCode=en

Business Daily Media